Explore
Settings

Settings

×

Reading Mode

Adjust the reading mode to suit your reading needs.

Font Size

Fix the font size to suit your reading preferences

Language

Select the language of your choice. NewsX reports are available in 11 global languages.
we-woman
Advertisement

How Infant Biomarkers Forecast Early Food Allergy Development – Researches Unveils!

Childhood food allergies are common but can be very serious or even deadly if not treated at early stages. In the process of creating a programme to stop food allergies, researchers at National Jewish Health have discovered early indicators of the illness. Findings of the study published in the Journal of Allergy & Clinical Immunology’s […]

How Infant Biomarkers Forecast Early Food Allergy Development – Researches Unveils!

Childhood food allergies are common but can be very serious or even deadly if not treated at early stages. In the process of creating a programme to stop food allergies, researchers at National Jewish Health have discovered early indicators of the illness.

Findings of the study published in the Journal of Allergy & Clinical Immunology’s March 2024 issue, skin tape strips were taken from babies’ forearms when they were just two months old for skin sampling method–a time before any indication of a food allergy could be seen.

What is the skin sampling method? 

The skin tape sampling method was created by experts at National Jewish Health, and it is soft and noninvasive for these very young patients. The lipids and surface proteins on the skin attach to the tape, which is subsequently removed to examine the specifics.

About the findings of the research

So, Evgeny Berdyshev, PhD, a researcher at National Jewish Health and first author of the study, concluded that if Early presence of abnormal lipids and proteins found on the skin then it might signal towards atopic dermatitis and food allergies.

“Ultimately, we want to identify people at risk for food allergy and address skin barrier abnormalities early to prevent the development of these conditions,” said Donald Leung, MD, head of the Division of Pediatric Allergy & Immunology in the Department of Pediatrics at National Jewish Health, and senior author of the study.
“This is just the first step,” said Dr. Leung. “We now have a biomarker for atopic dermatitis and food allergy – the abnormality is abnormal lipids, microbes and proteins. We are now testing newborn babies to determine whether we can prevent this abnormality. We put a lipid cream on the skin of the study participants, so it hopefully can penetrate the skin and infuse it with fatty acids. We are working to develop an anti-inflammatory cream as a result of this study.”

 

mail logo

Subscribe to receive the day's headlines from NewsX straight in your inbox